Tandem Diabetes Care (TNDM) EBT Margin (2013 - 2026)
Tandem Diabetes Care (TNDM) reported EBT Margin of 8.04% for Q1 2026, up 4404.0% on a YoY basis from 0.18% in Q1 2025, and down 593.81% quarter-over-quarter from 1.63% in Q4 2025.
Tandem Diabetes Care (TNDM) EBT Margin (2013 - 2026) Analysis & Trends
Tandem Diabetes Care has reported EBT Margin for 14 years, with the latest figure at 8.04% in Q1 2026.
- For the quarter ending Q1 2026, EBT Margin rose 4404.0% year-over-year to 8.04%; the trailing twelve-month figure through Mar 2026 stood at 9.54% (up 821.0% YoY), and the FY2025 full-year result was 19.74%, down 997.0% from the prior year.
- EBT Margin for Q1 2026 stood at 8.04%, down from 1.63% in the prior quarter.
- The five-year high for EBT Margin was 1.63% in Q4 2025, with the low at 72.96% in Q1 2023.
- Historically, EBT Margin has averaged 17.95% across 5 years, with a median of 13.4% in 2024.
- Annual changes were most pronounced in 2023 — EBT Margin sank 6364 bps — and 2024, when it soared 5234 bps.
- Tandem Diabetes Care's EBT Margin stood at 7.31% in 2022, then plunged by 118 bps to 15.93% in 2023, then surged by 100 bps to 0.01% in 2024, then jumped by 15240 bps to 1.63% in 2025, then slumped by 594 bps to 8.04% in 2026.
- The last three EBT Margin figures came in at 8.04% (Q1 2026), 1.63% (Q4 2025), and 10.09% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 12.98% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 14.12% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 15.57% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 22.33% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 27.84% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 4.87% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 22.61% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 9.84% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 19.17% |
| 10 | Tandem Diabetes Care | 1.04 Bn | 474.17 Mn | 136.79 Mn | -8.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.04% |
| Dec 31, 2025 | 1.63% |
| Sep 30, 2025 | -10.09% |
| Jun 30, 2025 | -23.98% |
| Mar 31, 2025 | -52.08% |
| Dec 31, 2024 | 0.01% |
| Sep 30, 2024 | -9.27% |
| Jun 30, 2024 | -13.40% |
| Mar 31, 2024 | -20.62% |
| Dec 31, 2023 | -15.93% |
| Sep 30, 2023 | -16.54% |
| Jun 30, 2023 | -17.66% |
| Mar 31, 2023 | -72.96% |
| Dec 31, 2022 | -7.31% |
| Sep 30, 2022 | -23.15% |
| Jun 30, 2022 | -6.47% |
| Mar 31, 2022 | -9.32% |
| Dec 31, 2021 | 5.29% |
| Sep 30, 2021 | 3.26% |
| Jun 30, 2021 | 2.36% |